GSDMD and systemic lupus erythematosus: Surprisingly, GSDMD knockout mice developed more severe lupus symptoms, including higher spleen/body weight ratios, increased proteinuria, and extensive renal and lung damage, alongside elevated mortality rates compared with imiquimod‐treated wild‐type mice.14